Burney Company’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-714
Closed -$401K 617
2025
Q4
$401K Buy
714
+61
+9% +$34.6K 0.01% 473
2025
Q3
$336K Hold
653
0.01% 486
2025
Q2
$205K Sell
653
-119
-15% -$35.7K 0.01% 558
2025
Q1
$235K Sell
772
-238
-24% -$80.1K 0.01% 537
2024
Q4
$336K Sell
1,010
-81
-7% -$27.5K 0.01% 486
2024
Q3
$364K Buy
1,091
+64
+6% +$24.3K 0.01% 486
2024
Q2
$423K Sell
1,027
-30
-3% -$11.9K 0.02% 455
2024
Q1
$427K Sell
1,057
-15
-1% -$5.27K 0.02% 466
2023
Q4
$329K Buy
1,072
+227
+27% +$61.3K 0.01% 482
2023
Q3
$205K Buy
+845
New +$216K 0.01% 546

Other funds holding MEDP

Burney Company's MEDP Position: Q1 2026 in Review

Burney Company sold out of Medpace (MEDP) in Q1 2026, closing a stake of 714 shares — an estimated $401K sold.

Burney Company first reported a position in MEDP in Q3 2023 and held it in 10 quarters. The position peaked at $427K in Q1 2024. 732 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Burney Company reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Burney Company sold 714 Medpace shares in Q1 2026, an estimated $401K.
  • Burney Company first reported a position in Medpace in Q3 2023 and held it in 10 quarters.
  • Burney Company's Medpace position peaked at $427K in Q1 2024.
  • 732 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Burney Company's 13F filing for Q1 2026, filed 29 Apr 2026.